New Jersey's powerful pharmaceutical industry, already under pressure to rein in prices, is facing new headwinds from a Trump ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

The Kuwait government aims to boost the medical sector with investment and support for the local drug producers.

As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...

Indian pharma CDMOs remain resilient, continuing to thrive due to favorable global factors. The B&K Securities report ...

Europe’s pharmaceutical firms are rushing to prepare for the potential fallout of U.S. import duties, even as analysts warn ...

With proper data governance, the pharma industry can improve patient-centricity in trials and bring lifesaving therapies to ...

As the Estée Lauder Cos. is looking to bulk up its innovation capabilities, it’s looking to another industry for its latest ...

The pharmaceutical industry has long relied on data-driven decision-making to advance drug discovery, improve clinical trials ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...